0001062993-23-022645.txt : 20231215 0001062993-23-022645.hdr.sgml : 20231215 20231215164848 ACCESSION NUMBER: 0001062993-23-022645 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spandow Oliver J. CENTRAL INDEX KEY: 0001749836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32288 FILM NUMBER: 231491055 MAIL ADDRESS: STREET 1: C/O 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEPHROS INC CENTRAL INDEX KEY: 0001196298 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133971809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 BUSINESS PHONE: 201.343.5202 MAIL ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-13 0001196298 NEPHROS INC NEPH 0001749836 Spandow Oliver J. C/O NEPHROS, INC. 380 LACKAWANNA PLACE SOUTH ORANGE NJ 07079 1 0 0 0 0 Common Stock 2023-12-13 4 A 0 14294 0 A 81604 D Stock Option (Right to Buy) 5.5755 2028-08-10 Common Stock 9466 9466 D Stock Option (Right to Buy) 5.8500 2028-12-19 Common Stock 5161 5161 D Stock Option (Right to Buy) 8.5700 2029-12-16 Common Stock 5568 5568 D Stock Option (Right to Buy) 8.0600 2031-01-06 Common Stock 6850 6850 D Stock Option (Right to Buy) 6.82 2031-12-14 Common Stock 7062 7062 D Stock Option (Right to Buy) 1.07 2032-01-05 Common Stock 7080 7080 D Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date. Fully exercisable. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25. /s/ Christopher Melsha as attorney-in-fact for Oliver Spandow pursuant to power of attorney previously filed. 2023-12-15